Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.7%

1 terminated out of 27 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
P 1 (1)
P 2 (2)
P 3 (3)

Trial Status

Completed9
Unknown7
Recruiting4
Active Not Recruiting2
Not Yet Recruiting1
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT02592499Not ApplicableActive Not RecruitingPrimary

Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure

NCT07534462Not Yet RecruitingPrimary

Echocardiographic Assessment of the Effect of Impella on Biventricular Function

NCT07633535CompletedPrimary

LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients

NCT04641416RecruitingPrimary

Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps

NCT04768322Not ApplicableRecruitingPrimary

LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients

NCT07382284RecruitingPrimary

Long-Term Survival After LVAD Implantation in End-Stage Heart Failure

NCT05353816Not ApplicableActive Not RecruitingPrimary

Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial

NCT07301788Completed

Donor Circadian Rhythm and Its Correlation With Prognosis After Heart Transplantation

NCT04951999Not ApplicableCompletedPrimary

AssocIation of PULSatility and Occurrence of Complications Related to Mechanically Assisted Circulatory Support

NCT06299176Phase 1Enrolling By Invitation

Whole Heart Radiotherapy for End-stage Heart Failure

NCT03966313TerminatedPrimary

Perioperative Modification of Hemostasis During Ventricular Assist Device Implantation

NCT04117295Not ApplicableSuspendedPrimary

Carmat TAH Early Feasibility Study

NCT06345521Recruiting

Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure

NCT06152562CompletedPrimary

Evaluation of Platelet Therapy Response in Left Ventricular Assist Device Patients

NCT06063811Unknown

Ventricular Tachycardia Ablation in LVAD Patients

NCT04782245Phase 2WithdrawnPrimary

Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List

NCT05928273Not ApplicableCompletedPrimary

Corheart 6 LVAS LTFU

NCT04205760Phase 3Unknown

Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device

NCT04351945Unknown

Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors

NCT04480151Completed

ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)

Scroll to load more

Research Network

Activity Timeline